4//SEC Filing
Inman Todd 4
Accession 0001213900-22-010598
CIK 0001448431other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:46 PM ET
Size
8.0 KB
Accession
0001213900-22-010598
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Inman Todd
Chief Technology Officer
Transactions
- Award
Restricted Stock Units
2022-03-01+2,313→ 2,313 total→ Common Stock (2,313 underlying) - Award
Stock Option
2022-03-01+4,690→ 4,690 totalExercise: $43.24Exp: 2027-03-01→ Common Stock (4,690 underlying)
Footnotes (3)
- [F1]The stock option vests in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F3]The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001858241
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:46 PM ET
- Size
- 8.0 KB